Skip to main content
. 2009 Aug 19;35(1):105–135. doi: 10.1038/npp.2009.109

Figure 16.

Figure 16

Chronic administration of the progesterone metabolite, allopregnanolone, blocked sustained fear measured with CRF-enhanced startle (left panel) but had no effect on phasic fear measured with fear-potentiated startle to a 3.7-s CS (right panel).